MVIS US Listed Biotech 25 Index

The MVIS US Listed Biotech 25 Index (MVBBH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the biotech industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from biotech related products and services, such as research and development, production, or marketing and sales of drugs based on genetic analysis and diagnostic equipment.

Components

The MVIS US Listed Biotech 25 Index counts currently 25 components. The full list of the components with the respective weights (as of latest close) is available below.

Items 1-25 of total 25
ComponentCountryWeight
CRISPR THERAPEUTICS AGCH1.18%
BIONTECH SEDE5.31%
ICON PLCIE5.23%
BEIGENE LTD-ADRKY3.13%
QIAGEN NVNL2.82%
NATERA INCUS1.85%
ILLUMINA INCUS4.38%
AMGEN INCUS8.02%
IQVIA HOLDINGS INCUS5.57%
SEAGEN INCUS4.30%
INCYTE CORPUS2.05%
BIOGEN INCUS4.02%
NOVAVAX INCUS3.12%
EXACT SCIENCES CORPUS2.92%
BIO-TECHNE CORPUS4.05%
REGENERON PHARMACEUTICALSUS5.35%
BIOMARIN PHARMACEUTICAL INCUS2.25%
10X GENOMICS INCUS1.62%
VERTEX PHARMACEUTICALS INCUS5.44%
CHARLES RIVER LABORATORIESUS3.93%
GUARDANT HEALTH INCUS2.36%
ALNYLAM PHARMACEUTICALS INCUS2.89%
GILEAD SCIENCES INCUS5.72%
INTELLIA THERAPEUTICS INCUS1.29%
MODERNA INCUS11.19%
Items 1-25 of total 25
Up